T1	Participants 71 99	anemic patients with cancer.
T2	Participants 216 255	patients with cancer-associated anemia.
T3	Participants 277 331	Eligible patients were randomly assigned at enrollment
T4	Participants 556 604	Three hundred sixty-five patients were enrolled.
T5	Participants 605 706	One hundred eighty-three patients were assigned to the 40K arm, and 182 were assigned to the 120K arm
T6	Participants 753 784	patients requiring transfusions
T7	Participants 938 979	Patients randomly assigned to the 40K arm
T8	Participants 1240 1263	Patients in the 40K arm
T9	Participants 1347 1371	patients in the 120K arm
